AR057180A1 - Formulacion farmaceutica de absorcion oral que comprende insulina, entre otros, y su metodo de administracion - Google Patents
Formulacion farmaceutica de absorcion oral que comprende insulina, entre otros, y su metodo de administracionInfo
- Publication number
- AR057180A1 AR057180A1 ARP060105216A ARP060105216A AR057180A1 AR 057180 A1 AR057180 A1 AR 057180A1 AR P060105216 A ARP060105216 A AR P060105216A AR P060105216 A ARP060105216 A AR P060105216A AR 057180 A1 AR057180 A1 AR 057180A1
- Authority
- AR
- Argentina
- Prior art keywords
- micelle
- insulin
- pharmaceutical formulation
- administration
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Una formulacion farmacéutica para absorber por la mucosa oral que incluye una cantidad efectiva de (a) un agente farmacéutico en forma de micela combinada como por ejemplo insulina, entre otros; (b) al menos un compuesto formador de micela seleccionado del grupo de sulfato alquilo de metal alcalino y monooleato de sorbitan polioxietileno; (c) un copolímero bloque de polioxietileno y polioxipropileno; (d) al menos un compuesto formador de micela adicional y (e) un disolvente adecuado. Proporciona además un dispensador de dosis graduado (aerosol y no aerosol) que contiene la presente formulacion y un método de administracion de insulina con un dispensador de dosis graduado que incluye administrar dosis multiples de una formulacion que contiene insulina antes y después de cada comida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA2005/001816 WO2007062494A1 (en) | 2005-11-30 | 2005-11-30 | Orally absorbed pharmaceutical formulation and method of administration |
Publications (1)
Publication Number | Publication Date |
---|---|
AR057180A1 true AR057180A1 (es) | 2007-11-21 |
Family
ID=38091821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105216A AR057180A1 (es) | 2005-11-30 | 2006-11-27 | Formulacion farmaceutica de absorcion oral que comprende insulina, entre otros, y su metodo de administracion |
Country Status (15)
Country | Link |
---|---|
US (2) | US20090214657A1 (es) |
EP (1) | EP1954242A4 (es) |
JP (1) | JP2009517410A (es) |
CN (1) | CN101309668A (es) |
AP (1) | AP2008004447A0 (es) |
AR (1) | AR057180A1 (es) |
AU (1) | AU2005338631B2 (es) |
BR (1) | BRPI0520704A2 (es) |
CA (1) | CA2630578C (es) |
EA (1) | EA200800979A1 (es) |
EC (1) | ECSP088403A (es) |
IL (1) | IL191531A0 (es) |
NZ (1) | NZ567601A (es) |
UY (1) | UY29905A1 (es) |
WO (1) | WO2007062494A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009015456A1 (en) * | 2007-07-30 | 2009-02-05 | Generex Pharmaceuticals Inc. | Pharmaceutical formulation in mixed micellar form and dispenser for oral delivery of agents as a spray |
CN101422431B (zh) * | 2007-12-28 | 2011-03-23 | 上海医药工业研究院 | 胰岛素经鼻给药制剂 |
BR122013025625B1 (pt) | 2008-10-17 | 2021-08-03 | Sanofi-Aventis Deutschland Gmbh | Composição farmacêutica, seu uso e método de preparação da mesma, kit e dispositivo |
CN100594929C (zh) * | 2009-06-24 | 2010-03-24 | 薛南荣 | 口服胰岛素药物及其制备方法 |
ES2676373T3 (es) | 2009-11-13 | 2018-07-19 | Sanofi-Aventis Deutschland Gmbh | Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina |
SI2498801T1 (en) | 2009-11-13 | 2018-06-29 | Sanofi-Aventis Deutschland Gmbh | A pharmaceutical composition containing desPro36Exendin-4 (1-39) -Lys6-NH2 and methionine |
CA2786953A1 (en) * | 2010-01-12 | 2011-07-21 | Florian Anders Foeger | Pharmaceutical compositions for oral administration of insulin peptides |
AU2011202239C1 (en) | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
RS55378B1 (sr) | 2010-08-30 | 2017-03-31 | Sanofi Aventis Deutschland | Upotreba ave0010 za proizvodnju leka za tretman diabetes mellitus tipa 2 |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
CN102228680B (zh) * | 2011-06-14 | 2013-02-27 | 中国人民解放军第三0二医院 | 胸腺肽的磷脂/胆盐复合胶束及其制备方法和制剂 |
EP2723321A4 (en) * | 2011-06-27 | 2015-07-01 | Univ Texas | RINGING PHARMACEUTICAL FORMULATIONS |
US9408893B2 (en) | 2011-08-29 | 2016-08-09 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
KR20200130511A (ko) | 2013-04-03 | 2020-11-18 | 사노피 | 장시간-작용 제형의 인슐린에 의한 당뇨병의 치료 |
US9687455B2 (en) | 2014-08-14 | 2017-06-27 | John Daniel Dobak | Sodium tetradecyl sulfate formulations for treatment of adipose tissue |
DK3006045T3 (en) | 2014-10-07 | 2017-07-17 | Cyprumed Gmbh | Pharmaceutical formulations for oral administration of peptide or protein drugs |
LT3229828T (lt) | 2014-12-12 | 2023-06-12 | Sanofi-Aventis Deutschland Gmbh | Insulino glargino/liksisenatido fiksuoto santykio kompozicija |
US9351945B1 (en) | 2015-02-27 | 2016-05-31 | John Daniel Dobak, III | Reduction of adipose tissue |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
US10905744B2 (en) | 2015-10-07 | 2021-02-02 | Cyprumed Gmbh | Pharmaceutical formulations for the oral delivery of peptide drugs |
US11166912B2 (en) | 2016-03-03 | 2021-11-09 | Ctt Pharma Inc. | Orally administrable composition |
US11298336B2 (en) | 2019-05-30 | 2022-04-12 | Soluble Technologies, Inc. | Water soluble formulation |
US11786475B2 (en) | 2020-07-22 | 2023-10-17 | Soluble Technologies Inc. | Film-based dosage form |
US12108809B1 (en) | 2022-04-15 | 2024-10-08 | Air 2, LLC | Aerosol pressurized delivery device and methods for manufacture and use of the same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
US5817321A (en) * | 1992-10-08 | 1998-10-06 | Supratek Pharma, Inc. | Biological agent compositions |
ATE198268T1 (de) * | 1992-10-08 | 2001-01-15 | Supratek Pharma Inc | Zusammensetzung von in mizellen eingeschlossenen antineoplastischen wirkstoffen |
TW402506B (en) * | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
JPH11292787A (ja) * | 1995-08-15 | 1999-10-26 | Asahi Chem Ind Co Ltd | 生理活性ペプチドを含有する経粘膜投与製剤 |
DE19733651A1 (de) * | 1997-08-04 | 1999-02-18 | Boehringer Ingelheim Pharma | Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole |
IL122084A (en) * | 1997-10-31 | 1999-09-22 | Lurident Ltd | Formulation for personal care with mucoadhesive properties |
US6063762A (en) * | 1997-12-05 | 2000-05-16 | Chong Kun Dang Corp. | Cyclosporin-containing microemulsion preconcentrate composition |
US6017545A (en) * | 1998-02-10 | 2000-01-25 | Modi; Pankaj | Mixed micellar delivery system and method of preparation |
US6436367B1 (en) * | 1998-12-21 | 2002-08-20 | Generex Pharmaceuticals Inc. | Aerosol formulations for buccal and pulmonary application |
US7087215B2 (en) * | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
US6312665B1 (en) * | 1998-12-21 | 2001-11-06 | Generex Pharmaceuticals Incorporated | Aerosol formulations for buccal and pulmonary application |
US6451286B1 (en) * | 1998-12-21 | 2002-09-17 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
US6375975B1 (en) * | 1998-12-21 | 2002-04-23 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary application |
WO2000074736A1 (en) * | 1999-06-04 | 2000-12-14 | Delrx Pharmaceutical Corporation | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
-
2005
- 2005-11-30 AP AP2008004447A patent/AP2008004447A0/xx unknown
- 2005-11-30 US US12/085,783 patent/US20090214657A1/en not_active Abandoned
- 2005-11-30 NZ NZ567601A patent/NZ567601A/en not_active IP Right Cessation
- 2005-11-30 BR BRPI0520704-5A patent/BRPI0520704A2/pt not_active IP Right Cessation
- 2005-11-30 EA EA200800979A patent/EA200800979A1/ru unknown
- 2005-11-30 CA CA2630578A patent/CA2630578C/en not_active Expired - Fee Related
- 2005-11-30 AU AU2005338631A patent/AU2005338631B2/en not_active Ceased
- 2005-11-30 CN CNA2005800520768A patent/CN101309668A/zh active Pending
- 2005-11-30 WO PCT/CA2005/001816 patent/WO2007062494A1/en active Application Filing
- 2005-11-30 EP EP05814246A patent/EP1954242A4/en not_active Withdrawn
- 2005-11-30 JP JP2008542566A patent/JP2009517410A/ja active Pending
-
2006
- 2006-11-08 UY UY29905A patent/UY29905A1/es not_active Application Discontinuation
- 2006-11-27 AR ARP060105216A patent/AR057180A1/es unknown
-
2008
- 2008-04-25 EC EC2008008403A patent/ECSP088403A/es unknown
- 2008-05-18 IL IL191531A patent/IL191531A0/en unknown
-
2012
- 2012-02-29 US US13/408,133 patent/US20120171259A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
UY29905A1 (es) | 2007-05-31 |
EA200800979A1 (ru) | 2008-10-30 |
AP2008004447A0 (en) | 2008-04-30 |
AU2005338631A1 (en) | 2007-06-07 |
US20090214657A1 (en) | 2009-08-27 |
CA2630578C (en) | 2014-04-15 |
WO2007062494A1 (en) | 2007-06-07 |
CA2630578A1 (en) | 2007-06-07 |
ECSP088403A (es) | 2008-05-30 |
NZ567601A (en) | 2010-12-24 |
EP1954242A1 (en) | 2008-08-13 |
US20120171259A1 (en) | 2012-07-05 |
CN101309668A (zh) | 2008-11-19 |
IL191531A0 (en) | 2008-12-29 |
AU2005338631B2 (en) | 2011-12-01 |
BRPI0520704A2 (pt) | 2009-05-19 |
EP1954242A4 (en) | 2012-08-01 |
JP2009517410A (ja) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR057180A1 (es) | Formulacion farmaceutica de absorcion oral que comprende insulina, entre otros, y su metodo de administracion | |
AR059350A1 (es) | Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva | |
ES2169087T3 (es) | Formulaciones orales de un antifungico. | |
PE20080765A1 (es) | Formas de dosificacion farmaceutica | |
ES2184310T3 (es) | Formulacion autoemulsionante para compuestos lipofilos acidos. | |
GT200600261A (es) | Formulaciones de diclofenac y metodos para usarlas | |
WO2007047371A3 (en) | Pharmaceutical packaging of an oral dosage combination | |
TN2009000504A1 (en) | Pharmaceutical formulation in mixed micellar form and dispenser for oral delivery of agents as a spray | |
FR2878161B1 (fr) | Forme medicamenteuse orale, solide et concue pour eviter le mesusage | |
UY28271A1 (es) | Compuestos químicos | |
AR070026A1 (es) | Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus | |
AR034813A1 (es) | Composiciones farmaceuticas y uso de las mismas | |
CY1118461T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν αναστολεα αρωματασης | |
AR057745A1 (es) | Formulaciones de disoluciones de hfc que contienen hidrocloruro de salbutamol o citrato de salbutamol | |
SG149054A1 (en) | Multiparticulate formulations for oral delivery | |
WO2013104892A8 (en) | Application of high dose compounds via inhalation | |
UY28366A1 (es) | Compuestos químicos | |
BRPI0607990A2 (pt) | formulação de um aerossol farmacêutico para inaladores dosimetrados pressurizados contendo um agente seqüestrante, uso do agente sequestrante, inalador de dosimetrado pressurizado e método de preenchimento do inalador de aerossol | |
DE60329968D1 (de) | Dosierungsformen enthaltend Thyroidhormone und deren Herstellungsverfahren | |
UY29561A1 (es) | Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
CR9941A (es) | Formacion farmaceutica de absorcion oral y su metodo de administracion | |
TR200601092T1 (tr) | İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar. | |
AR062152A1 (es) | Formulacion farmaceutica y su uso, y dispositivo de dosificacion controlada que contiene el mismo | |
UY30515A1 (es) | Formulacion farmaceutica y su uso, y dispositivo de dosificacion controlada que contiene el mismo | |
UA90346C2 (ru) | Фармацевтическая рецептура для перорального приема и способ введения пациенту |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |